Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation

Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation

AbstractContext Dihydromyricetin (DMY) is extracted from vine tea, a traditional Chinese herbal medicine with anti-cancer, liver protection, and cholesterol-lowering effects.Objective This study investigated the mechanism of DMY against hepatocellular carcinoma (HCC).Materials and methods Potential...

Full description

Bibliographic Details
Main Authors: Shuo Zhang, Ya-Ning Shi, Jia Gu, Peng He, Qi-Di Ai, Xu-Dong Zhou, Wei Wang, Li Qin
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Pharmaceutical Biology
Subjects:
Cholesterol
hepatocellular carcinoma cells
lipid raft
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2023.2234000

Internet

https://www.tandfonline.com/doi/10.1080/13880209.2023.2234000

Similar Items